Newsroom
Sorted by: Latest
-
Eyonis Inc, a Median Technologies Company, Wins “Rising Star” Digital Health & AI Award for eyonis® LCS Lung Cancer Screening
SOPHIA ANTIPOLIS, France & LAS VEGAS--(BUSINESS WIRE)--Regulatory News: Median Technologies (FR0011049824, ALMDT, “Median” or the “Company”), developer of eyonis®, a suite of artificial intelligence (AI) powered Software as a Medical Device (SaMD) for early cancer detection and diagnosis, announced today that Eyonis Inc., its U.S. subsidiary has been selected a winner of the 2026 Digital Health Hub Foundation Digital Health & AI Awards. Eyonis was named a “Rising Star” in the “Cancer, Scree...
-
Eyonis Inc, filiale de Median Technologies, remporte le prix « Rising Star » des Digital Health & AI Awards pour sa solution de dépistage du cancer du poumon eyonis® LCS
SOPHIA ANTIPOLIS, France & LAS VEGAS--(BUSINESS WIRE)--Regulatory News: Median Technologies (FR0011049824, ALMDT, « Median » ou la « Société »), développeur d’eyonis®, une suite de logiciels dispositifs médicaux (Software as a Medical Device, SaMD) basés sur l’intelligence artificielle (IA) pour la détection et le diagnostic précoces des cancers, annonce aujourd’hui que sa filiale américaine Eyonis Inc. est lauréate des Digital Health & AI Awards 2026 de la Digital Health Hub Foundation. Ey...
-
FPT se hisse à la 85e place du classement des ESN et sociétés de conseil en technologies en France, enregistrant une croissance significative de son chiffre d’affaires sur ce marché
PARIS--(BUSINESS WIRE)--Le groupe technologique mondial FPT s’est hissé à la 85e place du classement 2026 des entreprises de services numériques (ESN) et de conseil en technologies en France, établi par KPMG France et Numeum, gagnant ainsi 20 places par rapport à l’année précédente. Cette avancée fait suite à une croissance du chiffre d’affaires d’environ 50 % en France, témoignant de l’expansion des activités de l’entreprise et du renforcement de sa position concurrentielle sur le marché. Ce c...
-
Silicon Motion Showcases Next-Generation Enterprise Storage Solutions to Power Agentic AI Infrastructure at SC26
TAIPEI, Taiwan & MILPITAS, Calif.--(BUSINESS WIRE)--Silicon Motion Technology Corporation (NasdaqGS: SIMO), a global leader in designing and marketing NAND flash controllers for solid-state storage devices, today announced that it will showcase its PCIe Gen5 and PCIe Gen6 MonTitan® enterprise SSD controllers and reference platforms designed to address the evolving storage demands of AI factories, Agentic AI, and large-scale inference deployments at Supercomputing 2026 (SC26), taking place Novem...
-
Citibank UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- Re: LACE FUNDING 2025-1 PLC GBP 38,889,000.00 MATURING: 21-Nov-2074 ISIN: XS2982091790 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 21-Aug-2026 TO 23-Nov-2026 HAS BEEN FIXED AT 3.78 PCT DAY BASIS: ACTUAL/365(FIX) INTEREST PAYABLE VALUE 23-Nov-2026 WILL AMOUNT TO: GBP 378,498.31 PER GBP 38,889,000.00 DENOMINATION ...
-
TotalEnergies SE : Déclaration des Transactions sur Actions Propres
PARIS--(BUSINESS WIRE)--Regulatory News: Dans le cadre des autorisations consenties par l’Assemblée générale du 29 mai 2026 pour opérer sur ses actions et conformément à la réglementation relative aux rachats d'actions, TotalEnergies SE (Paris:TTE) (LSE:TTE) (NYSE:TTE) (LEI : 529900S21EQ1BO4ESM68) déclare ci-après les achats d’actions propres (FR0000120271) réalisés du 9 novembre au 13 novembre 2026 : Jour de la transaction Volume total journalier (en nombre de titres) Prix pondéré moyen journa...
-
TotalEnergies SE: Disclosure of Transactions in Own Shares
PARIS--(BUSINESS WIRE)--Regulatory News: In accordance with the authorizations given by the shareholders’ general meeting on May 29, 2026, to trade on its shares and pursuant to applicable law on share repurchase, TotalEnergies SE (Paris:TTE) (LSE:TTE) (NYSE:TTE) (LEI: 529900S21EQ1BO4ESM68) declares the following purchases of its own shares (FR0000120271) from November 9 to November 13, 2026: Transaction Date Total daily volume (number of shares) Daily weighted average purchase price of shares...
-
Citibank UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- Re: BANK OF AMERICA CORPORATION EUR 25,000,000.00 MATURING: 20-May-2030 ISIN: XS1232273018 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 18-Nov-2026 TO 18-Feb-2027 HAS BEEN FIXED AT 3.45 PCT DAY BASIS: 30/360 INTEREST PAYABLE VALUE 18-Feb-2027 WILL AMOUNT TO: EUR 215,312.5 PER EUR 25,000,000.00 DENOMINATION ...
-
Citibank UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- Re: HOPS HILL NO.4 PLC GBP 25,745,000.00 MATURING: 21-Apr-2056 ISIN: XS2802116561 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 21-Oct-2026 TO 23-Nov-2026 HAS BEEN FIXED AT 5.12 PCT DAY BASIS: ACTUAL/365(FIX) INTEREST PAYABLE VALUE 23-Nov-2026 WILL AMOUNT TO: GBP 125,535.71 PER GBP 27,100,000.00 DENOMINATION ...
-
Uniquity Bio Announces Statistically Significant and Clinically Meaningful Positive Topline Phase 2 Results for Solrikitug in Eosinophilic Esophagitis
MALVERN, Pa.--(BUSINESS WIRE)--Uniquity Bio, a clinical-stage drug development company focused on immunology and inflammation and backed by Blackstone Life Sciences, today announced positive topline data from ALAMERE, its Phase 2 clinical trial of solrikitug in eosinophilic esophagitis (EoE). Solrikitug, a highly potent monoclonal antibody targeting thymic stromal lymphopoietin (TSLP), demonstrated statistically significant and clinically meaningful results in both co-primary and key secondary...